Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Mechanical thrombectomy of M2 occlusions with distal access catheters using ADAPT.

Grieb D, Schlunz-Hendann M, Brinjikji W, Melber K, Greling B, Lanfermann H, Brassel F, Meila D.

J Neuroradiol. 2019 Jul;46(4):231-237. doi: 10.1016/j.neurad.2019.01.096. Epub 2019 Feb 13.

PMID:
30771378
2.

Delayed and incomplete treatment may result in dural fistula development in children with Vein of Galen malformation.

Meila D, Schmidt C, Melber K, Grieb D, Jacobs C, Jacobs C, Lanfermann H, Brassel F.

Interv Neuroradiol. 2018 Feb;24(1):82-87. doi: 10.1177/1591019917741755. Epub 2017 Nov 10.

3.

Vascular angular remodeling by kissing-Y stenting in wide necked intracranial bifurcation aneurysms.

Melber K, Meila D, Draheim P, Grieb D, Greling B, Schlunz-Hendann M, Brassel F.

J Neurointerv Surg. 2017 Dec;9(12):1233-1237. doi: 10.1136/neurintsurg-2016-012858. Epub 2016 Dec 5.

PMID:
27920207
4.

Endovascular treatment of head and neck arteriovenous malformations: long-term angiographic and quality of life results.

Meila D, Grieb D, Greling B, Melber K, Jacobs C, Hechtner M, Schmitz T, Schlunz-Hendann M, Lanfermann H, Brassel F.

J Neurointerv Surg. 2017 Sep;9(9):860-866. doi: 10.1136/neurintsurg-2016-012570. Epub 2016 Aug 26.

PMID:
27566490
5.

Endovascular treatment of complex intracranial aneurysms using Acandis Acclino stents.

Brassel F, Grieb D, Meila D, Schlunz-Hendann M, Greling B, Melber K.

J Neurointerv Surg. 2017 Sep;9(9):854-859. doi: 10.1136/neurintsurg-2016-012571. Epub 2016 Aug 24.

PMID:
27557944
6.

Fistulous-type vein of Galen malformation phantom model for endovascular training and research.

Meila D, Melber K, Grieb D, Jacobs C, Lanfermann H, Brassel F.

J Neurointerv Surg. 2017 Sep;9(9):880-886. doi: 10.1136/neurintsurg-2016-012568. Epub 2016 Aug 10.

PMID:
27510885
7.

Hydrocephalus in vein of Galen malformation: etiologies and therapeutic management implications.

Meila D, Grieb D, Melber K, Jacobs C, Maslehaty H, Petridis A, El Habony R, Lanfermann H, Scholz M, Brassel F.

Acta Neurochir (Wien). 2016 Jul;158(7):1279-84. doi: 10.1007/s00701-016-2836-y. Epub 2016 May 13.

PMID:
27173099
8.

Kissing-Y stenting for endovascular treatment of complex wide necked bifurcation aneurysms using Acandis Acclino stents: results and literature review.

Brassel F, Melber K, Schlunz-Hendann M, Meila D.

J Neurointerv Surg. 2016 Apr;8(4):386-95. doi: 10.1136/neurintsurg-2015-011691. Epub 2015 May 18. Review.

PMID:
25987589
9.

Stable platinum isotope measurements in presolar nanodiamonds by TEAMS.

Wallner A, Melber K, Merchel S, Ott U, Forstner O, Golser R, Kutschera W, Priller A, Steier P.

Nucl Instrum Methods Phys Res B. 2013 Jan;294(2-2):496-502.

10.

A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.

Buchmann P, Dembek C, Kuklick L, Jäger C, Tedjokusumo R, von Freyend MJ, Drebber U, Janowicz Z, Melber K, Protzer U.

Vaccine. 2013 Feb 6;31(8):1197-203. doi: 10.1016/j.vaccine.2012.12.074. Epub 2013 Jan 7.

PMID:
23306359
11.

Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.

Schirmbeck R, Dikopoulos N, Kwissa M, Leithäuser F, Lamberth K, Buus S, Melber K, Reimann J.

Eur J Immunol. 2003 Dec;33(12):3342-52.

12.

Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen.

Schirmbeck R, Böhm W, Fissolo N, Melber K, Reimann J.

Eur J Immunol. 2003 Sep;33(9):2429-38.

13.

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses.

Debin A, Kravtzoff R, Santiago JV, Cazales L, Sperandio S, Melber K, Janowicz Z, Betbeder D, Moynier M.

Vaccine. 2002 Jun 21;20(21-22):2752-63.

PMID:
12034102
15.

Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain.

Riedl P, Stober D, Oehninger C, Melber K, Reimann J, Schirmbeck R.

J Immunol. 2002 May 15;168(10):4951-9.

16.

The use of hirudin as universal anticoagulant in haematology, clinical chemistry and blood grouping.

Menssen HD, Melber K, Brandt N, Thiel E.

Clin Chem Lab Med. 2001 Dec;39(12):1267-77.

PMID:
11798089
17.

Measurement of hematological, clinical chemistry, and infection parameters from hirudinized blood collected in universal blood sampling tubes.

Menssen HD, Brandt N, Leben R, Müller F, Thiel E, Melber K.

Semin Thromb Hemost. 2001 Aug;27(4):349-56.

PMID:
11547357
19.

Methylotrophic yeast hansenula polymorpha as production organism for recombinant pharmaceuticals.

Gellissen G, Melber K.

Arzneimittelforschung. 1996 Sep;46(9):943-8. Review.

PMID:
8876947
20.
21.

Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.

Böhm W, Schirmbeck R, Elbe A, Melber K, Diminky D, Kraal G, van Rooijen N, Barenholz Y, Reimann J.

J Immunol. 1995 Oct 1;155(7):3313-21.

PMID:
7561024
22.

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.

Schirmbeck R, Deml L, Melber K, Wolf H, Wagner R, Reimann J.

Vaccine. 1995 Jun;13(9):857-65.

PMID:
7483809
24.
26.

Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.

Schirmbeck R, Melber K, Kuhröber A, Janowicz ZA, Reimann J.

J Immunol. 1994 Feb 1;152(3):1110-9.

PMID:
8301120
27.

Heterologous protein production in yeast.

Gellissen G, Melber K, Janowicz ZA, Dahlems UM, Weydemann U, Piontek M, Strasser AW, Hollenberg CP.

Antonie Van Leeuwenhoek. 1992 Aug;62(1-2):79-93. Review.

PMID:
1444338
28.

High-level expression of foreign genes in Hansenula polymorpha.

Gellissen G, Janowicz ZA, Weydemann U, Melber K, Strasser AW, Hollenberg CP.

Biotechnol Adv. 1992;10(2):179-89.

PMID:
14544533
29.

Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes.

Rodeck U, Melber K, Kath R, Menssen HD, Varello M, Atkinson B, Herlyn M.

J Invest Dermatol. 1991 Jul;97(1):20-6.

30.

Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha.

Janowicz ZA, Melber K, Merckelbach A, Jacobs E, Harford N, Comberbach M, Hollenberg CP.

Yeast. 1991 Jul;7(5):431-43.

PMID:
1897310
32.

Tumor promoters induce a transient expression of tumor-associated genes in both basal and differentiated cells of the mouse epidermis.

Krieg P, Finch J, Füstenberger G, Melber K, Matrisian LM, Bowden GT.

Carcinogenesis. 1988 Jan;9(1):95-100.

PMID:
3275504
33.

Molecular cloning of sequences activated during multi-stage carcinogenesis in mouse skin.

Melber K, Krieg P, Fürstenberger G, Marks F.

Carcinogenesis. 1986 Feb;7(2):317-22.

PMID:
3004776
34.

DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties.

Sauer G, Amtmann E, Melber K, Knapp A, Müller K, Hummel K, Scherm A.

Proc Natl Acad Sci U S A. 1984 Jun;81(11):3263-7.

Supplemental Content

Loading ...
Support Center